Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Unknown × Nalbuphine × Clear all

Phase

Status

Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Nalbuphine Allergy 1

Interventions

Metformin 14 Drug Therapy 11 Dexamethasone 11 Cytarabine 11 Cyclophosphamide 11 Cisplatin 11 Oxaliplatin 8 Carboplatin 8 ulipristal acetate 7 icotinib 7 Sodium Chloride 7 Radiotherapy 7 Paclitaxel 7 Idarubicin 7 Gemcitabine 7 Fluorouracil 7 Docetaxel 7 Vincristine 6 Leuprolide 6 Granulocyte Colony-Stimulating Factor 6 Dexmedetomidine 6 entecavir 5 Thalidomide 5 Surgical Procedures, Operative 5 Sorafenib 5 S 1 (combination) 5 Propranolol 5 Pemetrexed 5 Methotrexate 5 Etoposide 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05073744 2022-12-29

Nalbuphine Versus Morphine for Perioperative Tumor Ablation

Zhongda Hospital

Phase 4 Unknown

Nalbuphine Allergy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡